Trial Profile
Study assessing the effect of Transarterial chemoembolization (TACE) on hepatocellular carcinoma patients treated with sorafenib
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Dec 2015
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Pharmacodynamics; Therapeutic Use
- 11 Dec 2015 New trial record